Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
6.22
-0.13 (-2.05%)
At close: Sep 24, 2026, 4:00 PM EDT
6.15
-0.07 (-1.13%)
Pre-market: Sep 25, 2026, 4:00 AM EDT
Valneva SE Employees
Valneva SE had 620 employees as of June 30, 2026.
Employees
620
Change
n/a
Growth
n/a
Revenue / Employee
$263,390
Profits / Employee
-$290,499
Market Cap
576.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 620 | - | - |
| Dec 31, 2025 | 674 | -39 | -5.47% |
| Dec 31, 2024 | 713 | 37 | 5.47% |
| Dec 31, 2023 | 676 | -43 | -5.98% |
| Dec 31, 2022 | 719 | -43 | -5.64% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| MapLight Therapeutics | 133 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Altimmune | 57 |
VALN News
- 5 weeks ago - Valneva (VALN) Q2 2026 Earnings Call Transcript - The Motley Fool
- 5 weeks ago - Pfizer, Valneva announce EMA validation for PF-07307405 MAA - TheFly
- 5 weeks ago - Valneva Stock (VLN) Soars Over 20% On Lyme Disease Vaccine Hopes - TipRanks
- 5 weeks ago - Pfizer And Valneva's Lyme Vaccine Clears EMA Review Gate - Nasdaq
- 6 weeks ago - Pfizer, Valneva's Lyme Disease Vaccine Application Validated By EMA - Nasdaq
- 6 weeks ago - Pfizer Inc.: Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Finanz Nachrichten
- 6 weeks ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - GlobeNewsWire
- 6 weeks ago - Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Wallstreet:Online